Skip to main content

Want a detailed portfolio tracker?

Codexis (CDXS) P/E (2013 - 2026)

Codexis (CDXS) P/E from Dec 31, 2013 to Jul 21, 2026. The TTM Codexis (CDXS) P/E is -6.22. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Codexis (CDXS)

YearP/EChange
2026-6.22+93.72%
2025-3.21-41.85%
2024-5.52+116.35%
2023-2.55-73.88%
2022-9.77-89.74%
2021-95.18+74.69%
2020-54.49-27.94%
2019-75.61-4.48%
2018-79.16+513.69%
2017-12.90-62.89%
2016-34.76+55.85%
2015-22.30+333.22%
2014-5.15-5.95%
2013-5.47N/A

Comparison Codexis (CDXS) P/E with competitors

Codexis (CDXS) P/E is -6.22.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.07%
ENLVEnlivex Ltd0.07-101.20%
FGENFibroGen Inc0.24-103.86%
CHRSCoherus Biosciences Inc0.85-113.65%
FBIOFortress Biotech Inc0.95-115.26%
ORMPOramed Pharmaceuticals Inc1.50-124.17%
AGENAgenus Inc3.01-148.41%
INVAInnoviva Inc3.15-150.73%
VXRTVaxart Inc3.55-157.09%
CRMDCorMedix Inc3.63-158.36%
CVACCureVac N.V.4.45-171.50%
GLPGGalapagos NV4.86-178.15%
SRPTSarepta Therapeutics Inc4.88-178.52%
ABEOAbeona Therapeutics Inc5.39-186.65%
ABUSArbutus Biopharma Corp5.60-190.00%
ZVRAZevra Therapeutics Inc5.89-194.69%
SPROSpero Therapeutics Inc6.23-200.18%
CGENCompugen Ltd6.31-201.55%
RIGLRigel Pharmaceuticals6.87-210.53%
SLXNSilexion Therapeutics Corp7.30-217.35%
OMEROmeros Corporation9.26-248.91%
AUPHAurinia Pharmaceuticals Inc9.58-254.16%
PLXProtalix BioTherapeutics Inc10.89-275.17%
ACADAcadia Pharmaceuticals Inc11.73-288.64%
TBPHTheravance Biopharma Inc12.26-297.22%
ADMAAdma Biologics Inc12.42-299.73%
HRMYHarmony Biosciences Holdings Inc13.82-322.28%
SABSSAB Biotherapeutics Inc14.14-327.36%
NAGENiagen Bioscience Inc14.82-338.33%
INCYIncyte Corp15.82-354.48%
REGNRegeneron Pharmaceuticals Inc15.86-355.03%
PBYIPuma Biotechnology Inc17.32-378.50%
CPRXCatalyst Pharmaceuticals Inc17.44-380.49%
EXELExelixis Inc17.54-382.08%
TGTXTG Therapeutics Inc18.97-405.04%
MDXGMimedx Group Inc20.55-430.56%
XOMAXOMA Royalty Corp22.87-467.92%
ARGXArgen X SE24.30-490.81%
CTMXCytomX Therapeutics Inc24.82-499.22%
XOMAOXOMA Royalty Corp25.34-507.65%
HALOHalozyme Therapeutics Inc25.62-512.13%
XOMAPXOMA Royalty Corp25.67-512.88%
VRTXVertex Pharmaceuticals Inc27.99-550.27%
RPRXRoyalty Pharma plc - Class A28.69-561.41%
SLNOSoleno Therapeutics Inc29.02-566.69%
ASNDAscendis Pharma A/S30.09-583.90%
LGNDLigand Pharmaceuticals Inc - Class B37.91-709.78%
APLSApellis Pharmaceuticals Inc39.02-727.62%
BMRNBiomarin Pharmaceutical Inc42.21-778.94%
KRYSKrystal Biotech Inc45.34-829.31%
ONCBeiGene Ltd69.54-1218.50%
PHARPharming Group N.V.75.03-1306.72%
TECHBio-Techne Corp101.96-1739.91%
VCELVericel Corp109.92-1867.99%
ALNYAlnylam Pharmaceuticals Inc117.96-1997.36%
GMABGenmab140.29-2356.45%
TLXTelix Pharmaceuticals Ltd162.15-2708.08%
CORTCorcept Therapeutics Inc212.86-3523.62%